Andratschke N, Willmann J, Appelt AL, Alyamani N, Balermpas P, Baumert BG, et al. European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol. 2022;23(10):e469–e78.

Article  PubMed  Google Scholar 

Hellman S, Weichselbaum RR, Oligometastases. J Clin oncology: official J Am Soc Clin Oncol. 1995;13(1):8–10.

Article  CAS  Google Scholar 

Ost P, Reynders D, Decaestecker K, Fonteyne V, Lumen N, De Bruycker A, et al. Surveillance or Metastasis-Directed therapy for oligometastatic prostate Cancer recurrence: a prospective, randomized, Multicenter Phase II Trial. J Clin oncology: official J Am Soc Clin Oncol. 2018;36(5):446–53.

Article  CAS  Google Scholar 

Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy for the Comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin oncology: official J Am Soc Clin Oncol. 2020;38(25):2830–8.

Article  Google Scholar 

Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, et al. Outcomes of Observation vs Stereotactic Ablative Radiation for oligometastatic prostate Cancer: the ORIOLE phase 2 Randomized Clinical Trial. JAMA Oncol. 2020;6(5):650–9.

Article  PubMed  PubMed Central  Google Scholar 

Gomez DR, Blumenschein GR Jr, Lee JJ, Hernandez M, Ye R, Camidge DR, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17(12):1672–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu B, Liang Y, Li Q, Liu G, Wang F, Chen Z, et al. Local therapy for Oligoprogressive Disease in patients with Advanced Stage non-small-cell Lung Cancer harboring epidermal growth factor receptor mutation. Clin Lung Cancer. 2017;18(6):e369–e73.

Article  CAS  PubMed  Google Scholar 

Thompson R, Cheung P, Chu W, Myrehaug S, Poon I, Sahgal A, et al. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: dose and site of metastases matter. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2020;142:236–45.

Article  CAS  PubMed  Google Scholar 

Cheung P, Patel S, North SA, Sahgal A, Chu W, Soliman H, et al. Stereotactic radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients receiving tyrosine kinase inhibitor therapy: a phase 2 prospective Multicenter Study. Eur Urol. 2021;80(6):693–700.

Article  CAS  PubMed  Google Scholar 

Regnery S, Buchele C, Piskorski L, Weykamp F, Held T, Eichkorn T, et al. SMART ablation of lymphatic oligometastases in the pelvis and abdomen: clinical and dosimetry outcomes. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2022;168:106–12.

Article  PubMed  Google Scholar 

Ost P, Jereczek-Fossa BA, Van As N, Zilli T, Tree A, Henderson D, et al. Pattern of progression after stereotactic body radiotherapy for oligometastatic prostate Cancer nodal recurrences. Clin Oncol (R Coll Radiol (G B)). 2016;28(9):e115–20.

Article  CAS  Google Scholar 

Schröder C, Stiefel I, Tanadini-Lang S, Pytko I, Vu E, Guckenberger M, et al. Re-irradiation in the thorax - an analysis of efficacy and safety based on accumulated EQD2 doses. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2020;152:56–62.

Article  PubMed  Google Scholar 

Horne ZD, Dohopolski MJ, Clump DA, Burton SA, Heron DE. Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field. Practical radiation oncology. 2018;8(3):e117–e23.

Article  PubMed  Google Scholar 

Regnery S, Buchele C, Weykamp F, Pohl M, Hoegen P, Eichkorn T, et al. Adaptive MR-Guided stereotactic Radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations. Front Oncol. 2021;11:757031.

Article  PubMed  Google Scholar 

Henke L, Kashani R, Robinson C, Curcuru A, DeWees T, Bradley J, et al. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2018;126(3):519–26.

Article  PubMed  Google Scholar 

Finazzi T, Palacios MA, Spoelstra FOB, Haasbeek CJA, Bruynzeel AME, Slotman BJ, et al. Role of On-Table plan adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors. Int J Radiat Oncol Biol Phys. 2019;104(4):933–41.

Article  PubMed  Google Scholar 

Hoegen P, Katsigiannopulos E, Buchele C, Regnery S, Weykamp F, Sandrini E, et al. Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk. Clin translational radiation Oncol. 2023;39:100567.

Article  CAS  Google Scholar 

Henke LE, Kashani R, Hilliard J, DeWees TA, Curcuru A, Przybysz D, et al. In Silico Trial of MR-Guided midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in centrally located thoracic tumors. Int J Radiat Oncol Biol Phys. 2018;102(4):987–95.

Article  PubMed  Google Scholar 

Padgett KR, Simpson G, Asher D, Portelance L, Bossart E, Dogan N. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers. Phys Med. 2020;77:54–63.

Article  PubMed  Google Scholar 

Weykamp F, Katsigiannopulos E, Piskorski L, Regnery S, Hoegen P, Ristau J, et al. Dosimetric Benefit of Adaptive magnetic resonance-guided stereotactic body Radiotherapy of Liver Metastases. Cancers. 2022;14(24):6041.

Article  PubMed  PubMed Central  Google Scholar 

Bohoudi O, Bruynzeel AME, Tetar S, Slotman BJ, Palacios MA, Lagerwaard FJ. Dose accumulation for personalized stereotactic MR-guided adaptive radiation therapy in prostate cancer. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2021;157:197–202.

Article  CAS  PubMed  Google Scholar 

Alam S, Veeraraghavan H, Tringale K, Amoateng E, Subashi E, Wu AJ, et al. Inter- and intrafraction motion assessment and accumulated dose quantification of upper gastrointestinal organs during magnetic resonance-guided ablative radiation therapy of pancreas patients. Phys Imaging Radiat Oncol. 2022;21:54–61.

Article  PubMed  PubMed Central  Google Scholar 

Fredén E, Tilly D, Ahnesjö A. Adaptive dose painting for prostate cancer. Front Oncol. 2022;12:973067.

Article  PubMed  PubMed Central  Google Scholar 

Willigenburg T, van der Velden JM, Zachiu C, Teunissen FR, Lagendijk JJW, Raaymakers BW, et al. Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2022;171:182–8.

Article  PubMed  Google Scholar 

Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, et al. Safety and Efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. J Clin oncology: official J Am Soc Clin Oncol. 2019;37(15):1316–25.

Article  CAS  Google Scholar 

Hanna GG, Murray L, Patel R, Jain S, Aitken KL, Franks KN et al. UK Consensus on normal tissue dose constraints for stereotactic Radiotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)). 2018;30(1):5–14.

Timmerman R. A story of Hypofractionation and the table on the Wall. Int J Radiat Oncol Biol Phys. 2022;112(1):4–21.

Article  PubMed  Google Scholar 

Bohoudi O, Bruynzeel AME, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ, et al. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2017;125(3):439–44.

Article  CAS  PubMed  Google Scholar 

Klüter S, Schrenk O, Renkamp CK, Gliessmann S, Kress M, Debus J, et al. A practical implementation of risk management for the clinical introduction of online adaptive magnetic resonance-guided radiotherapy. Phys Imaging Radiat Oncol. 2021;17:53–7.

Article  PubMed  PubMed Central  Google Scholar 

Weistrand O, Svensson S. The ANACONDA algorithm for deformable image registration in radiotherapy. Med Phys. 2015;42(1):40–53.

Article  PubMed  Google Scholar 

Kadoya N, Nakajima Y, Saito M, Miyabe Y, Kurooka M, Kito S, et al. Multi-institutional validation study of commercially available deformable image Registration Software for thoracic images. Int J Radiat Oncol Biol Phys. 2016;96(2):422–31.

Article  PubMed  Google Scholar 

Hoegen P, Lang C, Akbaba S, Häring P, Splinter M, Miltner A, et al. Cone-Beam-CT guided adaptive Radiotherapy for locally Advanced Non-small Cell Lung Cancer enables Quality Assurance and Superior Sparing of healthy lung. Front Oncol. 2020;10:564857.

Article  PubMed  PubMed Central  Google Scholar 

Bohoudi O, Lagerwaard FJ, Bruynzeel AME, Niebuhr NI, Johnen W, Senan S, et al. End-to-end empirical validation of dose accumulation in MRI-guided adaptive radiotherapy for prostate cancer using an anthropomorphic deformable pelvis phantom. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2019;141:200–7.

Article  CAS  PubMed  Google Scholar 

Finazzi T, Palacios MA, Haasbeek CJA, Admiraal MA, Spoelstra FOB, Bruynzeel AME, et al. Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2020;144:46–52.

Article  PubMed  Google Scholar 

Brock KK, Mutic S, McNutt TR, Li H, Kessler ML. Use of image registration and fusion algorithms and techniques in radiotherapy: report of the AAPM Radiation Therapy Committee Task Group No. 132. Med Phys. 2017;44(7):e43–e76.

Article  CAS  PubMed  Google Scholar 

Murr M, Brock KK, Fusella M, Hardcastle N, Hussein M, Jameson MG, et al. Applicability and usage of dose mapping/accumulation in radiotherapy. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2023;182:109527.

Article  PubMed